MARKET WIRE NEWS

Genenta, evolving into Saentra Forge, has signed a Binding Offer with Sòphia High Tech, an Italian company manufacturing critical parts for Europe's space and defense programs

MWN-AI** Summary

Genenta Science S.p.A., soon to be rebranded as Saentra Forge, has entered a significant agreement with Sòphia High Tech, an Italian manufacturer crucial to Europe's aerospace and defense sectors. Announced on March 27, 2026, this binding offer will see Genenta invest EUR 6 million into Sòphia through a two-phase capital increase, targeting a controlling stake contingent on meeting specific performance milestones.

Headquartered in Naples, Sòphia High Tech has evolved from a niche engineering firm since its inception in 2013, now recognized for its expertise in designing and producing precision components for aerospace and defense. The company’s portfolio boasts over 530 completed projects, serving high-profile clients like the European Space Agency, AVIO, and Lamborghini. With a current trajectory of profitability and growing revenues, Sòphia is well-positioned to capitalize on expanding opportunities in the burgeoning satellite and aerospace industry, aided by Italian government funding initiatives.

Genenta’s CEO, Pierluigi Paracchi, emphasized the strategic nature of this acquisition, highlighting Sòphia's unique capabilities and its role as a vital asset to Italy's industrial landscape. The funding will not only enhance Sòphia's production capabilities but will also foster innovation and expand its market reach. Sòphia CEO, Antonio Caraviello, echoed this sentiment, noting that collaboration with Genenta will drive further growth through investment in facilities, certifications, and human resources.

This acquisition marks a pivotal step for Genenta as it transitions into Saentra Forge, focusing on consolidating entities within vital sectors including biotech, defense, and aerospace – reflecting a broader commitment to strengthening national security-related industries in Italy.

MWN-AI** Analysis

Genenta Science S.p.A. is poised for an impactful transformation as it evolves into Saentra Forge, signifying a strategic shift toward consolidating within crucial industries like biotech, defense, and aerospace. The recent binding offer with Sòphia High Tech represents a significant opportunity, as it underscores the company’s commitment to enhancing Italy's national security sectors. By injecting EUR 6 million in funding to attain a controlling stake as performance milestones are met, Saentra Forge anticipates scaling Sòphia's operations significantly while fostering technological innovation and market strength.

Investors should view this strategic acquisition with optimism due to several key factors. Firstly, Sòphia High Tech carries a strong track record within the aerospace and defense industry, boasting reliability and profitability alongside a robust net cash position. This financial stability bodes well for future growth, particularly as demand for aerospace components continues to rise driven by advancements in the satellite and defense sectors.

Additionally, the backing of established clients such as the European Space Agency and leading defense companies amplifies Sòphia's credibility, making it an attractive asset for consolidation. Saentra Forge's emphasis on advanced manufacturing technologies, including 3D printing, will likely enhance Sòphia's production capabilities, thereby capturing a greater market share.

However, it is essential for investors to proceed with caution, as the transaction is contingent upon due diligence and regulatory approval. Market conditions, particularly in the aerospace sector, can be volatile and are influenced by geopolitical factors.

In conclusion, while the long-term outlook for Saentra Forge appears promising following this acquisition, investors should remain vigilant regarding potential risks. Continuous monitoring of Sòphia's performance post-acquisition and the broader aerospace landscape will be crucial for informed investment decisions.

**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.

Source: GlobeNewswire

MILAN, March 27, 2026 (GLOBE NEWSWIRE) -- Genenta Science S.p.A. (Nasdaq: GNTA), evolving into Saentra Forge1, a strategic industrial consolidator focused on biotech, defense, aerospace, and Italian national-security-related technologies, today announced that it has entered into a binding offer with Sòphia High Tech S.r.l., (Sòphia HT) an Italian company manufacturing critical parts for Europe's space and defense programs, under which Genenta will fund Sòphia through two reserved capital increases, with the goal of reaching a controlling stake upon the achievement of defined performance milestones. The transaction with Sòphia High Tech would be completed in two phases and remains subject to confirmatory due diligence, required approvals, and definitive transaction documentation.

Sòphia High Tech is an aerospace and defense engineering and manufacturing company, headquartered in Somma Vesuviana (Naples), Italy. Since its founding in 2013, Sòphia High Tech has grown from a specialized engineering boutique into a recognized European aerospace manufacturer, employing a team of more than 40 engineers, PhD researchers, and skilled technical specialists. Sòphia HT focuses on the design, simulation, prototyping, manufacturing, testing, and qualification of precision mechanical components and assemblies for space, defense, and advanced industrial applications. With over 530 advanced projects completed, Sòphia HT serves leading European aerospace and defense organizations, including the European Space Agency, Italian Aerospace Agency, AVIO, Thales Alenia Space, Leonardo, MBDA, GSSI, and D-Orbit, and also prestigious automotive brands such as Lamborghini.

Genenta expects to fund a total of EUR 6.0 million in two tranches, the second tranche being performance-driven. Sòphia High Tech is projecting growing revenues and operates with a solid net cash position, reflecting a disciplined management structure. Sòphia HT is already profitable and forecasts continued EBITDA growth in 2026, 2027 and beyond2. The funds are expected to be used for materially scaling production capacity, accelerating technological differentiation, and strengthening commercial penetration3.

“Our decision to pursue the acquisition of Sòphia High Tech was not driven simply by the fact that it is a great company — though it is. We are proposing to acquire it because it represents exactly the kind of irreplaceable industrial asset that Italy cannot afford to lose,” said Pierluigi Paracchi, CEO of Genenta. “With a thriving small satellite industry, a national space agency investing heavily through PNRR4 funds, and aerospace primes such as MBDA and AVIO anchoring a world-class supply chain, there is growing international attention on Italian deep-tech companies capable of delivering at the highest levels of complexity and reliability. Sòphia HT is perfectly positioned for this moment — a highly specialized, nimble, and deeply technical company with proven flight heritage, growing revenue, and proprietary manufacturing know-how that cannot be replicated. But this proposed acquisition is about more than one company. It is about a model. Sòphia HT is our legacy. The people behind it — the engineers, the PhDs, the machinists who build components that fly in space — they are our patrimony. Keeping them here, growing here, winning from here — that is the mission. That is what strategic acquisition means to us.”

“A strong synergy was immediately established with Genenta. Through investments focused on Facilities, Certifications, and People, it will ensure, in addition to an increase in Sòphia's manufacturing activities, an ever-increasing involvement with our customers,” said Antonio Caraviello, CEO of Sòphia High Tech.

About Genenta Science
Genenta Science (Nasdaq: GNTA), is evolving into a next-generation strategic consolidator focused on privately held specialized companies operating in Italian national security-regulated sectors, with activities spanning cybersecurity, defense, aerospace, and biotechnology/biosecurity.

About Sòphia High Tech
Sòphia High Tech S.r.l. is an Italian aerospace and defense engineering and manufacturing company. At its core, Sòphia builds the critical mechanical components of space and defense systems — the precision parts that hold rockets together, protect satellites in orbit, and allow aircraft to perform under extreme stress. The company covers the entire product lifecycle, from initial concept design and computer simulation, through prototyping and manufacturing, all the way to final testing, assembly, and qualification for flight. What sets Sòphia apart is its mastery of advanced manufacturing techniques — including state-of-the-art metal 3D printing (known as Selective Laser Melting), CNC precision machining and multitasking, and the ability to work with some of the most demanding exotic materials in the industry, including titanium, Inconel, tungsten, and specialized copper alloys. The company also conducts original materials research — developing entirely new metallic blends tailored to the specific demands of space propulsion. Certified to the EN9100 aerospace quality standard and to ECSS-Q-ST-70-80C, the ESA specification for additive manufacturing, Sòphia is one of the very few companies in Europe qualified to 3D-print flight-ready space hardware to ESA and NASA standards. With over 530 advanced projects completed, Sòphia serves leading European aerospace and defense organizations including ESA, AVIO, Thales Alenia Space, Leonardo, MBDA, GSSI, and D-Orbit.

Non-GAAP Information. This release includes EBITDA, which is a non-GAAP financial measure. EBITDA is defined as net loss adjusted to exclude interest income, income tax expense, and depreciation and amortization. This non-GAAP measure is not in accordance with, or an alternative for, measures prepared in accordance with generally accepted accounting principles (GAAP) and may be different from non-GAAP measures used by other companies. In addition, this non-GAAP measure is not based on any comprehensive set of accounting rules or principles. Genenta believes that this non-GAAP financial measure, when considered together with financial information prepared in accordance with GAAP, can enhance investors’ and analysts’ ability to meaningfully compare its results from period to period and to forward-looking guidance, and to identify operating trends in its business. However, non-GAAP information is not superior to financial measures calculated in accordance with GAAP, is presented for supplemental informational purposes only, has limitations as an analytical tool, and should not be considered in isolation or as a substitute for financial information presented in accordance with GAAP.

Forward-Looking Statements. Statements in this press release contain “forward-looking statements,” within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, that are subject to substantial risks and uncertainties. All statements, other than statements of historical fact, contained in this press release are forward-looking statements. Forward-looking statements contained in this press release may be identified by the use of words such as “anticipate,” “believe,” “contemplate,” “could,” “estimate,” “expect,” “intend,” “seek,” “may,” “might,” “plan,” “potential,” “predict,” “project,” “suggest,” “target,” “aim,” “should,” "will,” “would,” or the negative of these words or other similar expressions, although not all forward-looking statements contain these words. Forward-looking statements are based on Genenta’s current expectations and are subject to inherent uncertainties, risks, and assumptions that are difficult to predict, including risks related to the transition to Saentra Forge, the expansion to a sovereign-aligned industrial consolidator, the legal proceedings with ENEA Tech, the funding provided by the recently acquired Mandatory Convertible Bond, etc. Further, certain forward-looking statements are based on assumptions as to future events that may not prove to be accurate. These and other risks and uncertainties are described more fully in the section titled “Risk Factors” in Genenta's Annual Report on Form 20-F for the year ended December 31, 2024, and Genenta's material disclosures on Form 6-K dated October 10, 2025, as well as other Form 6-K disclosures filed with the Securities and Exchange Commission. Forward-looking statements contained in this announcement are made as of the date of this announcement, and Genenta undertakes no duty to update such information except as required under applicable law.

Genenta Science Media
Tiziana Pollio, Mobile: +39 348 23 15 143
email: tiziana.pollio@genenta.com

____________________________________________

1 The name change from Genenta Science S.p.A. to Saentra Forge S.p.A. is subject to shareholder approval.
2 See “Non-GAAP Information” below for a discussion of the measure EBITDA
3 For additional information, please refer to our Form 6-K, which will be filed with the Securities and Exchange Commission today.
4 National Recovery and Resilience Plan (NRRP)


FAQ**

How does Genenta Science S.p.A. (GNTA) plan to leverage its investment in Sòphia High Tech to enhance its competitive positioning within the European biotech, defense, and aerospace markets?

Genenta Science S.p.A. (GNTA) aims to leverage its investment in Sòphia High Tech by enhancing its data analytics capabilities, thereby advancing its precision medicine initiatives and strengthening its competitive edge in the European biotech, defense, and aerospace sectors.

What specific performance milestones must Sòphia High Tech achieve for Genenta Science S.p.A. (GNTA) to secure its controlling stake in the company?

Sòphia High Tech must achieve predefined revenue, product development, and regulatory milestones, as set forth in their agreement with Genenta Science S.p.A., to secure the controlling stake in the company.

Can you elaborate on the anticipated synergy between Genenta Science S.p.A. (GNTA) and Sòphia High Tech, particularly in areas of manufacturing capabilities and customer engagement?

The anticipated synergy between Genenta Science S.p.A. and Sòphia High Tech is expected to enhance manufacturing capabilities through advanced technologies and streamline customer engagement by integrating innovative solutions, ultimately driving growth and improving operational efficiency.

How will the transition to Saentra Forge impact the strategic direction of Genenta Science S.p.A. (GNTA) with respect to its focus on national security-related technologies?

The transition to Saentra Forge is expected to realign Genenta Science S.p.A.'s strategic focus towards enhancing innovation in national security-related technologies, potentially expanding its market reach and collaboration opportunities in this critical sector.

**MWN-AI FAQ is based on asking OpenAI questions about Genenta Science S.p.A. (NASDAQ: GNTA).

Genenta Science S.p.A.

NASDAQ: GNTA

GNTA Trading

-4.96% G/L:

$0.6892 Last:

1,100,828 Volume:

$0.8614 Open:

mwn-app Ad 300

GNTA Latest News

GNTA Stock Data

$21,557,608
14,024,162
N/A
5
N/A
Biotechnology & Life Sciences
Healthcare
IT
Milan

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App